Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12339 | 849 | 33.0 | 72% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
79 | 26608 | DIABETES CARE//DIABETES EDUCATOR//DIABETES TECHNOLOGY & THERAPEUTICS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MULTIPLE CAUSE | Author keyword | 3 | 60% | 0% | 3 |
2 | CHRONIC COMPLICATIONS | Author keyword | 2 | 20% | 1% | 11 |
3 | DATASUS | Address | 1 | 100% | 0% | 2 |
4 | DIABETES MELLITUS MORTALITY | Author keyword | 1 | 50% | 0% | 2 |
5 | ENDOCRINOL DIABETOL CARDIOL | Address | 1 | 50% | 0% | 2 |
6 | INSULIN TREATED DIABETES MELLITUS | Author keyword | 1 | 29% | 0% | 4 |
7 | STANDARDISED MORTALITY RATIO | Author keyword | 1 | 19% | 1% | 6 |
8 | RASZEJA HOSP | Address | 1 | 33% | 0% | 3 |
9 | CHILDHOOD ONSET DIABETES | Author keyword | 1 | 33% | 0% | 2 |
10 | ESTIMATED GLUCOSE DISPOSAL RATE | Author keyword | 1 | 33% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PITTSBURGH EPIDEMIOLOGY | 35 | 35% | 10% | 81 |
2 | GLUCOSE DISPOSAL RATE | 24 | 91% | 1% | 10 |
3 | NATIONWIDE COHORTS | 11 | 100% | 1% | 6 |
4 | RELATIVE MORTALITY | 10 | 48% | 2% | 15 |
5 | EURODIAB PROSPECTIVE COMPLICATIONS | 8 | 28% | 3% | 25 |
6 | ASSOCIATION COHORT | 8 | 52% | 1% | 11 |
7 | MELLITUS IDDM MORBIDITY | 6 | 100% | 0% | 4 |
8 | CAUSE OF DEATH | 3 | 57% | 0% | 4 |
9 | REGISTRY POPULATION | 3 | 100% | 0% | 3 |
10 | ALLEGHENY COUNTY | 3 | 24% | 1% | 11 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Type 1 diabetes, metabolic syndrome and cardiovascular risk | 2014 | 11 | 64 | 45% |
Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks? | 2013 | 17 | 52 | 37% |
Insulin resistance and hyperglycaemia in cardiovascular disease development | 2014 | 15 | 115 | 23% |
Epidemiology of Cardiovascular Disease in Patients with Type 1 Diabetes: European Perspective | 2014 | 5 | 48 | 44% |
Type 1 diabetes, hyperglycaemia, and the heart | 2008 | 47 | 99 | 39% |
Cause-specific mortality in diabetes: recent changes in trend mortality | 2012 | 12 | 47 | 38% |
Cardiovascular risk in double diabetes mellitus-when two worlds collide | 2012 | 13 | 75 | 32% |
Excess mortality in Type 1 diabetes diagnosed in childhood and adolescence: a systematic review of population-based cohorts | 2015 | 0 | 19 | 79% |
Cardiovascular complications in type 1 diabetes mellitus | 2010 | 6 | 14 | 64% |
Mortality in people diagnosed with type 2 diabetes at an older age: a systematic review | 2006 | 21 | 24 | 58% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DATASUS | 1 | 100% | 0.2% | 2 |
2 | ENDOCRINOL DIABETOL CARDIOL | 1 | 50% | 0.2% | 2 |
3 | RASZEJA HOSP | 1 | 33% | 0.4% | 3 |
4 | VUK VRHOVAC CLIN DIABET ENDOCRINOL METAB DIS | 1 | 17% | 0.5% | 4 |
5 | BARBARA DAVIS DIABET | 1 | 12% | 0.7% | 6 |
6 | AUSTRIAN DIALYSIS TRANSPLANTAT REGISTRY | 1 | 50% | 0.1% | 1 |
7 | BIALYSTOK UNIV CHILDRENS HOSP | 1 | 50% | 0.1% | 1 |
8 | CCBR BRASIL | 1 | 50% | 0.1% | 1 |
9 | CENT FUNDUS PHOTOG READING | 1 | 50% | 0.1% | 1 |
10 | CORPORACIO SANITARIA | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000200267 | DIABETES PREVALENCE//HOSPITAL ADMISSION RATES//ALLIANCE CLIN TRIALS |
2 | 0.0000130408 | CARBOHYDRATE COUNTING//FLEXIBLE INTENSIVE INSULIN THERAPY//POPULATION BASED TRIAL |
3 | 0.0000120114 | SILENT MYOCARDIAL ISCHAEMIA//SILENT CORONARY ARTERY DISEASE//SILENT MYOCARDIAL ISCHEMIA |
4 | 0.0000117254 | DIABETIC GLOMERULOPATHY//NON DIABETIC RENAL DISEASE//STRUCTURAL FUNCTIONAL RELATIONSHIPS |
5 | 0.0000095610 | ACCELERATOR HYPOTHESIS//NUTR METAB DIS CLIN//BETA CELL AUTOIMMUNITY |
6 | 0.0000094371 | CORE DIABETES MODEL//DIABETES RELATED COMPLICATIONS//ROYAL NEW ZEALAND GEN PRACTITIONERS UNIT |
7 | 0.0000092323 | NEPHROL ENDOCRINOL P//GLYCATED LDL//GLYCATED APOLIPOPROTEIN B |
8 | 0.0000078939 | IDOP//DIABET OLDER PEOPLE IDOP//ADMINISTRATIVE HEALTH CARE UTILIZATION DATA |
9 | 0.0000078743 | INTERMITTENT GLUCOSE//POSTPRANDIAL HYPERGLYCEMIA//GLYCEMIC VARIABILITY |
10 | 0.0000076095 | DIABETIC RETINOPATHY//RETINOPATHY ING//TELEOPHTHALMOLOGY |